Nasdaq · CIK 0001914605
ECBK ECB Bancorp, Inc. /MD/
Insider trading from SEC Form 4. Last filing May 1, 2026. Close $21.12 on Oct 9, 2026, +42% from the 52-week low and -2% from the high.
ECB Bancorp, Inc. /MD/ (ECBK) has 11 SEC Form 4 filings on file from 5 insiders, the latest filed on May 1, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
8 open-market trades have been scored at ECBK. The newest: Brandon Lavertu (CFO) bought $716 of stock on Apr 30, 2026, filed May 1, 2026, scored 17 (weak). The largest of the 8 shown: Maura Ellen Sullivan (director) bought $59k on Dec 8, 2025, scored 30 (weak). 2 insiders bought within 14 days of each other around Feb 24, 2025.
ECBK closed at $21.12 on Oct 9, 2026, 42% above its 52-week low and 2% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ECB Bancorp, Inc. /MD/, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Brandon Lavertu CFO buy | $716 40 shares | +0% | +21% from low-4% from high | |
| 36Weak | Maura Ellen Sullivan director buy | $41k 2,200 shares | +63% | +31% from low0% from high | |
| 30Weak | Maura Ellen Sullivan director buy | $59k 3,500 shares | - | +29% from low-5% from high | |
| 25Weak | Richard J O'Neil Jr President and CEO buy | $20k 1,250 shares | +5% | +21% from low-8% from high | |
| 43Moderate | Brandon Lavertu CFO buy | $26k 1,828 shares | +6% | - | |
| 39Weak | Brandon Lavertu CFO buy | $45k 3,122 shares | +7% | - | |
| 42Moderate | John A CITRANO EVP and COO buy | $43k 3,050 shares | +5% | - | |
| 38Weak | John A CITRANO EVP and COO buy | $52k 3,675 shares | +7% | - |
Transactions
The newest 50 of 112 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +10 | $17.85 | $179 | 32,393 | May 1, 2026 |
| Apr 30, 2026 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +10 | $17.88 | $179 | 32,403 | May 1, 2026 |
| Apr 30, 2026 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +10 | $17.91 | $179 | 32,413 | May 1, 2026 |
| Apr 30, 2026 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +10 | $17.92 | $179 | 32,423 | May 1, 2026 |
| Dec 18, 2024 | Joseph Sachetta director | MOption exercise Common Stock | +5,832 | $11.80 | $69k | 17,496 | Mar 20, 2026 |
| Dec 18, 2024 | Joseph Sachetta director | MOption exercise Stock Optionsderivative | -5,832 | $0.00 | $0 | 23,328 | Mar 20, 2026 |
| Feb 9, 2026 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +2,200 | $18.50 | $41k | 5,700 | Feb 9, 2026 |
| Dec 17, 2025 | Maura Ellen Sullivan director | AGrant or award Common Stock | +1,150 | $0.00 | $0 | 1,150 | Dec 19, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +361 | $16.65 | $6,011 | 361 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +200 | $16.78 | $3,356 | 561 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +76 | $16.80 | $1,277 | 637 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +100 | $16.81 | $1,681 | 737 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +100 | $16.82 | $1,682 | 837 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +100 | $16.83 | $1,683 | 937 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +300 | $16.84 | $5,052 | 1,237 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +500 | $16.85 | $8,425 | 1,737 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +700 | $16.86 | $12k | 2,437 | Dec 9, 2025 |
| Dec 8, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +500 | $16.90 | $8,450 | 2,937 | Dec 9, 2025 |
| Dec 9, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +400 | $16.95 | $6,780 | 3,337 | Dec 9, 2025 |
| Dec 9, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +100 | $17.04 | $1,704 | 3,437 | Dec 9, 2025 |
| Dec 9, 2025 | Maura Ellen Sullivan director | POpen-market purchase Common Stockindirect: By Spouse | +63 | $17.05 | $1,074 | 3,500 | Dec 9, 2025 |
| Sep 16, 2025 | Richard J O'Neil Jr President and CEO | POpen-market purchase Common Stockindirect: By IRA | +1,250 | $15.85 | $20k | 27,355 | Sep 18, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +200 | $14.40 | $2,880 | 30,755 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +50 | $14.43 | $721 | 30,805 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +250 | $14.43 | $3,608 | 31,055 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +50 | $14.43 | $722 | 31,105 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +50 | $14.44 | $722 | 31,155 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +100 | $14.44 | $1,444 | 31,255 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +75 | $14.45 | $1,083 | 31,330 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +103 | $14.45 | $1,488 | 31,433 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +200 | $14.45 | $2,889 | 31,633 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +100 | $14.47 | $1,447 | 31,733 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +125 | $14.47 | $1,809 | 31,858 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +200 | $14.48 | $2,896 | 32,058 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +50 | $14.48 | $724 | 32,108 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +50 | $14.49 | $724 | 32,158 | Feb 25, 2025 |
| Feb 24, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stock | +225 | $14.49 | $3,260 | 32,383 | Feb 25, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +75 | $14.30 | $1,073 | 45,075 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +50 | $14.38 | $719 | 45,125 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +75 | $14.38 | $1,079 | 45,200 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +700 | $14.40 | $10k | 45,900 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +150 | $14.41 | $2,161 | 46,050 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +75 | $14.45 | $1,084 | 46,125 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +50 | $14.45 | $723 | 46,175 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +75 | $14.46 | $1,084 | 46,250 | Feb 24, 2025 |
| Feb 20, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +100 | $14.48 | $1,448 | 46,350 | Feb 24, 2025 |
| Feb 21, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +50 | $14.12 | $706 | 46,400 | Feb 24, 2025 |
| Feb 21, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +100 | $14.30 | $1,430 | 46,500 | Feb 24, 2025 |
| Feb 21, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +100 | $14.31 | $1,431 | 46,600 | Feb 24, 2025 |
| Feb 21, 2025 | Brandon Lavertu CFO | POpen-market purchase Common Stockindirect: By IRA | +50 | $14.39 | $720 | 46,650 | Feb 24, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- John A CITRANOEVP and COO
- Brandon LavertuCFO
- Richard J O'Neil JrPresident and CEO
- Joseph Sachettadirector
- Maura Ellen Sullivandirector
Questions about ECBK
Answered from the filings on this page, as of the latest one.
Are insiders buying ECBK?
No. In the last 90 days no insider at ECB Bancorp, Inc. /MD/ bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ECBK on the open market?
Brandon Lavertu (CFO) bought $716 of ECBK on Apr 30, 2026 and filed the Form 4 on May 1, 2026. InsiderTell scored 17 (weak).
How many insiders file Form 4 at ECB Bancorp, Inc. /MD/?
5 people have filed a Form 4 at ECB Bancorp, Inc. /MD/, among them John A CITRANO (EVP and COO), Brandon Lavertu (CFO), Richard J O'Neil Jr (President and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.